Federal Register / Vol. 62, No. 89 / Thursday, May 8, 1997 / Notices 25211 factors in Title 21, United States Code, Sched- Sched- Section 823(a) and determined that the Drug ule Drug ule registration of Pharmacia & Upjohn Company to manufacture 2,5- Betamethadol (9609) ...... I Morphine (9300) ...... II Dimethoxyamphetamine is consistent Norlevorphanol (9634) ...... I Para-Fluorofentanyl (9812) ...... I The firm plans to manufacture small with the public interest at this time. Alpha-methylfentanyl (9814) ...... I Therefore, pursuant to 21 U.S.C. § 823 Acetyl-alpha-methylfentanyl (9815) I quantities of the listed controlled and 28 CFR 0.100 and 0.104, the Acting Beta-hydroxyfentanyl (9830) ...... I substances for incorporation in drug of Deputy Assistant Administrator, Office Beta-hydroxy-3-methylfentanyl I abuse detection kits. of Diversion Control, hereby orders that (9831). Any other such applicant and any the application submitted by the above Alpha-Methylthiofentanyl (9832) ..... I person who is presently registered with firm for registration as a bulk 3-Methylthiofentanyl (9833) ...... I DEA to manufacture such substances Thiofentanyl (9835) ...... I manufacturer of the basic class of Phenmetrazine (1631) ...... II may file comments or objections to the controlled substance listed above is Glutethimide (2550) ...... II issuance of the above application. granted. Cocaine (9041) ...... II Any such comments or objections Dated: March 31, 1997. Codeine (9050) ...... II may be addressed, in quintuplicate, to Terrance W. Woodworth, Levomethorphan (9210) ...... II the Acting Deputy Assistant Levorphanol (9220) ...... II Acting Deputy Assistant Administrator, Office Administrator, Office of Diversion of Diversion Control, Drug Enforcement Control, Drug Enforcement Administration. No comments or objections have been received. Administration, United States [FR Doc. 97–11925 Filed 5–7–97; 8:45 am] DEA has considered the factors in title Department of Justice, Washington, DC BILLING CODE 4410±09±M 21, United States Code, Section 823(a) 20537, Attention: DEA Federal Register and determined that the registration of Representative (CCR), and must be filed Radian International LLC to no later than July 7, 1997. DEPARTMENT OF JUSTICE manufacture the listed controlled Dated: March 31, 1997. Drug Enforcement Administration substances is consistent with the public Terrance W. Woodworth, interest at this time. Therefore, pursuant Acting Deputy Assistant Administrator, Office Manufacturer of Controlled to 21 U.S.C. § 823 and 28 CFR 0.100 and of Diversion Control, Drug Enforcement Substances; Notice of Registration 0.104, the Acting Deputy Assistant Administration. Administrator, Office of Diversion [FR Doc. 97–11927 Filed 5–7–97; 8:45 am] By Notice dated November 19, 1996, Control, hereby orders that the BILLING CODE 4410±09±M and published in the Federal Register application submitted by the above firm on December 24, 1996, (61 FR 67853), for registration as a bulk manufacturer Radian International LLC, 8501 North of the basic classes of controlled DEPARTMENT OF JUSTICE Mopac Blvd., P.O. Box 201088, Austin, substances listed above is granted. Texas 78720, made application by letter Immigration and Naturalization Service to the Drug Enforcement Administration Dated: March 31, 1997. (DEA) to be registered to manufacture Terrance W. Woodworth, Agency Information Collection small quantities of controlled Acting Deputy Assistant Administrator, Office Activities: Proposed Collection; substances for drug reference standards of Diversion Control, Drug Enforcement Comment Request as a bulk manufacturer of the basic Administration. classes of controlled substances listed [FR Doc. 97–11926 Filed 5–7–97; 8:45 am] ACTION: Extenstion of existing below: BILLING CODE 4410±09±M collection; Affidavit of support.

Sched- The Office of Management and Budget Drug ule DEPARTMENT OF JUSTICE (OMB) approval is being sought for the information collection listed below. Alpha-Ethyltryptamine (7249) ...... I Drug Enforcement Administration This proposed information collection 3,4,5-Trimethoxyamphetamine I was previously published in the Federal (7390). Manufacturer of Controlled Register on March 3, 1997, at 62 FR 4-Bromo-2,5- I Substances; Notice of Application dimethoxyamphetamine (7391). 9452, allowing for a 60-day public 4-Bromo-2,5- I Pursuant to Section 1301.43(a) of Title comment period. No comments were dimethoxyphenethylamine (7392). 21 of the Code of Federal Regulations received by the Immigration and 4-Methyl-2,5- I (CFR), this is notice that on March 17, Naturalization Service. The purpose of dimethoxyamphetamine (7395). 1997, Roche Diagnostic Systems, Inc., this notice is to allow an additional 30 2,5-Dimethoxyamphetamine (7396) I 1080 U.S. Highway 202, Somerville, days for public comments. Comments 2,5-Dimethoxy-4-ethylamphetamine I New Jersey 08876–3771, made are encouraged and will be accepted (7399). until June 9, 1997. This process is 5-Methoxy-3,4- I application by renewal to the Drug methylenedioxyamphetamine Enforcement Administration (DEA) for conducted in accordance with 5 CFR (7401). registration as a bulk manufacturer of Part 1320.10. N-Hydroxy-3,4- I the basic classes of controlled Written comments and/or suggestions methylenedioxyamphetamine substances listed below: regarding the item(s) contained in this (7402). notice, especially regarding the Bufotenine (7433) ...... I Drug Sched- estimated public burden and associated Codeine-N-oxide (9053) ...... I ule response time, should be directed to the Heroin (9200) ...... I Morphine-N-oxide (9307) ...... I Lysergic acid diethylamide (7315) .. I Office of Management and Budget, Pholcodine (9314) ...... I Tetrahydrocannabinols (7370) ...... I Office of Regulatory Affairs, Attention: Alphamethadol (9605) ...... I Phencyclidine (7471) ...... II Department of Justice Desk Officer, Betcetylmethadol (9607) ...... I Methadone (9250) ...... II Washington, DC 20530. Additionally,